The Impact of a 48-hour Fast with or Without Exercise on Immune Cell Metabolism and Glycemic Control in Healthy Active Adults
NCT ID: NCT06737224
Last Updated: 2025-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
15 participants
INTERVENTIONAL
2025-01-10
2025-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Glutathione on Immunity in Individuals Training for a Marathon
NCT03725241
Optimized Carbohydrate Fueling to Enhance Physical Performance During Energy Deficit
NCT06394401
Ketone Supplements and Substrate Oxidation and Physical Performance
NCT04737694
Clinical Trial on Rapid Immune Modulating Effects
NCT07206407
Ability of Beta-glucan Supplementation to Augment Immune Function
NCT03769012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fasting + Exercise (FAST+EX): fasting + exercise condition
48-hour fast with 60 minutes of cycling on the first and second day of the fast.
Fasting + Exercise (FAST+EX): fasting + exercise condition
Participants will complete a 48-hour fast. One hour of exercise will be performed on each morning of the fast.
Fasting only (FAST): Non-exercise fasting condition
48-hour fast with no structured exercise on fasting days.
Fasting only (FAST): Non-exercise fasting condition
Participant will complete a 48-hour fast. No structured exercise will be performed during each of the fasting days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fasting + Exercise (FAST+EX): fasting + exercise condition
Participants will complete a 48-hour fast. One hour of exercise will be performed on each morning of the fast.
Fasting only (FAST): Non-exercise fasting condition
Participant will complete a 48-hour fast. No structured exercise will be performed during each of the fasting days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physically active (engaging in ≥150 minutes of weekly moderate to vigorous physical activity).
Exclusion Criteria
* Individuals currently following a ketogenic diet, low-calorie diet, periodic fasting regimen, or consuming ketogenic supplements (e.g., exogenous ketone drinks).
* Cigarette/vaping smoking.
* Physical limitation that will impair the ability of the participant to perform exercise.
* Individuals having a body mass index (BMI) over 30 kg/m2.
* Cancer diagnosis in the past 5 years.
* Taking anti-inflammatory drugs (e.g., ibuprofen, aspirin, naproxen).
* Being unable to read or communicate in English.
19 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonathan Little
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of British Columbia Okanagan Campus
Kelowna, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Jonathan Little Principal Investigator, Professor Little, Ph.D
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H24-01732
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.